A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification
Purpose We studied the predictive value of [ 18 F]fluorodeoxyglucose-positron emission tomography ( 18 FDG-PET) for assessing disease-free (DFS) and overall survival (OS) in esophageal and esophagogastric junction cancer. Materials and methods A literature search (PUBMED/MEDLINE, EMBASE, Cochrane)...
Saved in:
Published in | Journal of gastrointestinal surgery Vol. 18; no. 5; pp. 894 - 905 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.05.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
We studied the predictive value of [
18
F]fluorodeoxyglucose-positron emission tomography (
18
FDG-PET) for assessing disease-free (DFS) and overall survival (OS) in esophageal and esophagogastric junction cancer.
Materials and methods
A literature search (PUBMED/MEDLINE, EMBASE, Cochrane) was performed to identify full papers with
18
FDG-PET and survival data, using indexing terms and free text words. Studies with >10 patients with locally advanced esophageal cancer, presenting sequential or at least one post-adjuvant treatment
18
FDG-PET data and Kaplan–Meier survival curves with >6 months median follow-up period were included. We performed a meta-analysis for DFS and OS using the hazard ratio (HRs) as outcome measure. Sources of heterogeneity study were also explored.
Results
We identified 26 eligible studies including a total of 1,544 patients (average age 62 years, 82 % males). The TNM distribution was as follows: stage I 7 %, II 24 %, III 53 % and IV 15 %. The pooled HRs for complete metabolic response versus no response were 0.51 for OS (95 % CI, 0.4–0.64; P < 0.00001) and 0.47 for DFS (95 % CI, 0.38–0.57; P < 0.00001), respectively. No statistical heterogeneity was present. To explore sources of clinical heterogeneity, we also realised subgroup and regression analyses. Taken into account the moderate correlation between OS and DFS (ρ = 0.54), we used joint bivariate random regression model. These analyses did not show a statistically significant impact of study characteristics and PET modalities on the pooled outcome estimates.
Conclusion
Despite methodological and clinical heterogeneity, metabolic response on
18
FDG-PET is a significant predictor of long-term survival data. |
---|---|
AbstractList | Purpose
We studied the predictive value of [
18
F]fluorodeoxyglucose-positron emission tomography (
18
FDG-PET) for assessing disease-free (DFS) and overall survival (OS) in esophageal and esophagogastric junction cancer.
Materials and methods
A literature search (PUBMED/MEDLINE, EMBASE, Cochrane) was performed to identify full papers with
18
FDG-PET and survival data, using indexing terms and free text words. Studies with >10 patients with locally advanced esophageal cancer, presenting sequential or at least one post-adjuvant treatment
18
FDG-PET data and Kaplan–Meier survival curves with >6 months median follow-up period were included. We performed a meta-analysis for DFS and OS using the hazard ratio (HRs) as outcome measure. Sources of heterogeneity study were also explored.
Results
We identified 26 eligible studies including a total of 1,544 patients (average age 62 years, 82 % males). The TNM distribution was as follows: stage I 7 %, II 24 %, III 53 % and IV 15 %. The pooled HRs for complete metabolic response versus no response were 0.51 for OS (95 % CI, 0.4–0.64; P < 0.00001) and 0.47 for DFS (95 % CI, 0.38–0.57; P < 0.00001), respectively. No statistical heterogeneity was present. To explore sources of clinical heterogeneity, we also realised subgroup and regression analyses. Taken into account the moderate correlation between OS and DFS (ρ = 0.54), we used joint bivariate random regression model. These analyses did not show a statistically significant impact of study characteristics and PET modalities on the pooled outcome estimates.
Conclusion
Despite methodological and clinical heterogeneity, metabolic response on
18
FDG-PET is a significant predictor of long-term survival data. |
Author | Krug, Bruno D’Hondt, Lionel Borght, Thierry Vander Crott, Ralph Bertrand, Claude Schollaert, Pascaline |
Author_xml | – sequence: 1 givenname: Pascaline surname: Schollaert fullname: Schollaert, Pascaline organization: Nuclear Medicine Division, CHU UCL Mont-Godinne – Dinant, Université Catholique de Louvain – sequence: 2 givenname: Ralph surname: Crott fullname: Crott, Ralph organization: Institute of Health and Society, Université Catholique de Louvain – sequence: 3 givenname: Claude surname: Bertrand fullname: Bertrand, Claude organization: Surgery, CHU UCL Mont-Godinne – Dinant, Université Catholique de Louvain – sequence: 4 givenname: Lionel surname: D’Hondt fullname: D’Hondt, Lionel organization: Oncology, CHU UCL Mont-Godinne – Dinant, Université Catholique de Louvain – sequence: 5 givenname: Thierry Vander surname: Borght fullname: Borght, Thierry Vander organization: Nuclear Medicine Division, CHU UCL Mont-Godinne – Dinant, Université Catholique de Louvain – sequence: 6 givenname: Bruno surname: Krug fullname: Krug, Bruno email: bruno.krug@uclouvain.be organization: Nuclear Medicine Division, CHU UCL Mont-Godinne – Dinant, Université Catholique de Louvain, Institute of Health and Society, Université Catholique de Louvain |
BookMark | eNp9UMtOwzAQtBBIPD-Am3_AYMd5OMeqlJcQIAqIW7RJNq2r1ka2E9Tf4gtxW7gieb3r0cysNcdk31iDhJwLfiE4Ly69EDnPGBcpS1KlWLJHjoQqJEvzJN-PMy8FS7Ls45Ace7_gXBRcqCPyPaLTtQ-4gqAb-oKDxi9qOxrmSJ8dtroJekD6DsseN7hQ11c37HnySrWhE28_5zBDWFIw7d_TzsAHF93uexPV1tAxmAYdHXUh3o9ooV30A5hAx3NcWQethi0vns3eae8GPUTTpz40dhWB4CKh082WdkoOOlh6PPvtJ-TtevI6vmUPTzd349EDaxKVBpZ1PGuKQkqVCsCyrSWPpWoEyUvoWpmoFiGHTEgoy7qoUeXYZnXGeSrTPJUnROx8G2e9d9hVn06vwK0rwatN6NUu9CqGXm1Cr5KoSXYaH7lmhq5a2N6Z-M1_RD9Lcond |
CitedBy_id | crossref_primary_10_1016_j_jviscsurg_2018_02_003 crossref_primary_10_1097_SLA_0000000000001902 crossref_primary_10_2967_jnumed_114_141424 crossref_primary_10_1007_s00428_017_2232_x crossref_primary_10_1007_s12149_019_01429_7 crossref_primary_10_1016_j_canrad_2020_02_007 crossref_primary_10_1371_journal_pone_0210055 crossref_primary_10_1111_dote_12479 crossref_primary_10_1016_j_ctrv_2018_06_012 crossref_primary_10_1016_S1283_0798_20_43783_0 crossref_primary_10_1016_j_cpet_2017_05_001 crossref_primary_10_1186_s12885_020_07044_4 crossref_primary_10_1016_j_jchirv_2017_11_007 crossref_primary_10_1016_j_ejca_2016_02_007 crossref_primary_10_1016_j_crad_2016_02_023 crossref_primary_10_1007_s11864_015_0352_6 crossref_primary_10_3389_fonc_2016_00072 crossref_primary_10_3390_cancers13061255 crossref_primary_10_1097_RLU_0000000000000661 crossref_primary_10_1097_RLU_0000000000002840 crossref_primary_10_1016_j_soc_2024_02_002 crossref_primary_10_1371_journal_pone_0137036 crossref_primary_10_1245_s10434_015_4764_0 crossref_primary_10_1016_j_ijsu_2015_06_056 crossref_primary_10_3390_cancers14123035 crossref_primary_10_1097_MNM_0000000000001168 crossref_primary_10_1080_0284186X_2017_1328127 crossref_primary_10_1016_S1282_9129_20_43697_9 crossref_primary_10_1007_s00330_015_3860_7 crossref_primary_10_1007_s11864_014_0301_9 crossref_primary_10_3748_wjg_v26_i35_5256 crossref_primary_10_1007_s11523_017_0540_3 |
Cites_doi | 10.7326/0003-4819-140-3-200402030-00010 10.1016/j.ejso.2009.01.012 10.1200/JCO.2006.08.2305 10.2967/jnumed.108.057232 10.1097/SLA.0b013e3181bc9c0d 10.1016/j.jclinepi.2013.05.014 10.1007/s00259-005-0028-8 10.1007/s11307-008-0169-9 10.1002/sim.2524 10.1200/JCO.2010.30.7702 10.1016/S1470-2045(07)70244-9 10.1016/j.ejca.2007.04.001 10.1200/JCO.2006.06.7801 10.2967/jnumed.110.085803 10.1002/cncr.25431 10.1016/j.athoracsur.2007.03.094 10.1001/jama.1995.03530080061042 10.1097/RLU.0b013e318219b0c0 10.1007/s00261-007-9241-1 10.1200/JCO.2003.04.013 10.2967/jnumed.110.079566 10.1016/j.athoracsur.2008.05.019 10.1002/sim.1185 10.1097/SLA.0b013e318155a7d1 10.1016/j.athoracsur.2006.03.072 10.1200/JCO.2004.07.122 10.1016/j.surg.2008.06.026 10.3748/wjg.v17.i46.5059 10.1093/annonc/mdf081 10.1136/bmj.324.7335.477 10.1016/S1470-2045(07)70039-6 10.1097/COC.0b013e31803993f8 10.1148/radiol.09091324 10.1136/bmj.327.7414.557 10.1186/1471-2288-7-3 10.1097/SLA.0b013e3181fb8dde 10.1016/j.athoracsur.2004.04.046 10.1056/NEJMoa1112088 10.1016/S0003-4975(99)00974-1 10.3322/caac.20107 10.1007/s00259-012-2325-3 10.1053/j.semnuclmed.2005.12.002 10.1053/j.seminoncol.2010.11.012 10.1056/NEJMra050276 10.1016/j.clon.2011.09.006 10.1002/cncr.24604 10.1097/00000658-200103000-00002 10.1007/s11307-010-0330-0 10.1002/cncr.20585 10.1007/s00259-011-1858-1 10.1007/s00259-007-0521-3 10.3109/0284186X.2011.643822 10.1200/JCO.2001.19.12.3058 10.1007/s10147-011-0278-3 10.1007/s11121-013-0377-7 10.5144/1658-3876.2010.179 10.1016/j.jtcvs.2008.02.016 10.1259/bjr/29946900 10.1016/j.ijrobp.2011.12.029 10.1002/cncr.26591 |
ContentType | Journal Article |
Copyright | The Society for Surgery of the Alimentary Tract 2014 |
Copyright_xml | – notice: The Society for Surgery of the Alimentary Tract 2014 |
DBID | AAYXX CITATION |
DOI | 10.1007/s11605-014-2488-2 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-4626 |
EndPage | 905 |
ExternalDocumentID | 10_1007_s11605_014_2488_2 |
GroupedDBID | --- --K -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1B1 1N0 203 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAEDT AAFGU AAHNG AAIAL AAJKR AALRI AANXM AANZL AAQFI AAQXK AARHV AARTL AATNV AATVU AAUYE AAWCG AAXUO AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMAC ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADMUD ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFJLC AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP D-I DDRTE DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FDB FEDTE FERAY FFXSO FGOYB FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Q G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG5 HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV KPH LLZTM M1P M41 M4Y MA- N4W N9A NAPCQ NPVJJ NQ- NQJWS NU0 O9- O93 O9I O9J OAM P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 QOR QOS R2- R89 R9I RIG RNI ROL RPX RPZ RSV RZK S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 WOW YLTOR Z45 Z5O Z7U Z7V Z7W Z7X Z82 Z83 Z87 ZMTXR ZOVNA AACDK AAJBT AAYXX AAYZH ABAKF ACAOD ACRPL ACZOJ ADNMO AEFQL AFBBN AFJKZ AGQEE AGRTI AIGIU AITUG ALIPV AMRAJ CITATION H13 |
ID | FETCH-LOGICAL-c284t-5f05c7733841ae9db30db38bea309afd328dea6a513a99b7be86ed5b500434643 |
IEDL.DBID | AGYKE |
ISSN | 1091-255X |
IngestDate | Fri Dec 06 03:42:03 EST 2024 Sat Dec 16 12:07:12 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | FDG-PET Overall survival Esophageal cancer Disease-free survival |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c284t-5f05c7733841ae9db30db38bea309afd328dea6a513a99b7be86ed5b500434643 |
PageCount | 12 |
ParticipantIDs | crossref_primary_10_1007_s11605_014_2488_2 springer_journals_10_1007_s11605_014_2488_2 |
PublicationCentury | 2000 |
PublicationDate | 2014-05-01 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston |
PublicationTitle | Journal of gastrointestinal surgery |
PublicationTitleAbbrev | J Gastrointest Surg |
PublicationYear | 2014 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | Roedl, Harisinghani, Colen, Fischman, Blake, Mathisen (CR20) 2008; 86 Riley, Abrams, Lambert, Sutton, Thompson (CR25) 2007; 26 Swisher, Maish, Erasmus, Correa, Ajani, Bresalier (CR40) 2004; 78 Kwee (CR11) 2010; 254 Reid, Lachs, Feinstein (CR56) 1995; 274 Korst, Kansler, Port, Lee, Kerem, Altorki (CR21) 2006; 82 Wieder, Brucher, Zimmermann, Becker, Lordick, Beer (CR42) 2004; 22 CR36 CR35 Krause, Herrmann, Wieder, Zum Buschenfelde (CR4) 2009; 50 CR33 Luketich, Friedman, Weigel, Meehan, Keenan, Townsend (CR57) 1999; 68 Esteves, Schuster, Halkar (CR12) 2006; 36 CR32 van Hagen, Hulshof, van Lanschot, Steyerberg, van Berge Henegouwen, Wijnhoven (CR3) 2012; 366 Smyth, Shah (CR9) 2011; 17 Whiting, Rutjes, Reitsma, Glas, Bossuyt, Kleijnen (CR55) 2004; 140 Makino, Miyata, Yamasaki, Fujiwara, Takiguchi, Nakajima (CR39) 2010; 148 Higuchi, Yasuda, Yano, Doki, Miyata, Tatsumi (CR31) 2008; 136 Lordick, Ott, Krause, Weber, Becker, Stein (CR38) 2007; 8 Knottnerus, van Weel, Muris (CR59) 2002; 324 Juweid, Stroobants, Hoekstra, Mottaghy, Dietlein, Guermazi (CR62) 2007; 25 Murthy, Patnana, Xiao, Rohren, Hofstetter, Swisher (CR49) 2010; 78 Mamede, Abreu, Oliva, Nose, Mamon, Gerbaudo (CR16) 2007; 30 Roedl, Halpern, Colen, Sahani, Fischman, Blake (CR19) 2009; 11 Chua, Dickson, Groves (CR10) 2011; 38 Port, Lee, Korst, Liss, Meherally, Christos (CR18) 2007; 84 Vallbohmer, Holscher, DeMeester, DeMeester, Salo, Peters (CR5) 2010; 252 Zum Buschenfelde, Herrmann, Schuster, Geinitz, Langer, Becker (CR45) 2011; 52 Patnana, Murthy, Xiao, Rohren, Hofstetter, Swisher (CR51) 2010; 116 Gebski, Burmeister, Smithers, Foo, Zalcberg, Simes (CR2) 2007; 8 Lijmer, Bossuyt, Heisterkamp (CR58) 2002; 21 Wong, Walker-Dilks, Raifu (CR8) 2012; 24 Makino, Doki, Miyata, Yasuda, Yamasaki, Fujiwara (CR48) 2008; 144 Kim, Ryu, Kim, Ahn, Kim, Park (CR37) 2007; 43 Riley, Abrams, Sutton, Lambert, Thompson (CR24) 2007; 7 Jemal, Bray, Center, Ferlay, Ward, Forman (CR1) 2011; 61 Cuenca, Hennequin, Hindie, Rivera, Vercellino, Baruch-Hennequin (CR60) 2013; 40 Ott, Weber, Lordick, Becker, Busch, Herrmann (CR50) 2006; 24 Wong, Chambers (CR14) 2008; 33 Wieder, Ott, Lordick, Becker, Stahl, Herrmann (CR43) 2007; 34 Malik, Lucey, Duffy, Wilson, McNamara, Keogan (CR15) 2010; 51 Weber, Ott, Becker, Dittler, Helmberger, Avril (CR41) 2001; 19 Swisher, Erasmus, Maish, Correa, Macapinlac, Ajani (CR53) 2004; 101 Whiting, Rutjes, Westwood, Mallett, Group (CR54) 2013; 66 Brucher, Weber, Bauer, Fink, Avril, Stein (CR27) 2001; 233 Siewert, Lordick, Ott, Stein, Weber, Becker (CR52) 2007; 246 Yang, Yang, Han, Feng, Ma, Kong (CR44) 2011; 36 Flamen, Van Cutsem, Lerut, Cambier, Haustermans, Bormans (CR30) 2002; 13 Suttie, Welch, Park (CR13) 2009; 35 Abdelsalam, Bazarbashi, Abouzied, Amin, Soudy, Rahal (CR26) 2010; 3 Duong, Demitriou, Weih, Thompson, Williams, Thomas (CR29) 2006; 33 Higgins, Thompson, Deeks, Altman (CR22) 2003; 327 Javeri, Xiao, Rohren, Lee, Liao, Hofstetter (CR34) 2009; 115 Lorenzen, Panzram, Keller, Lordick, Herrmann, Becker (CR47) 2011; 13 Juweid, Cheson (CR7) 2006; 354 Downey, Akhurst, Ilson, Ginsberg, Bains, Gonen (CR28) 2003; 21 Monjazeb, Riedlinger, Aklilu, Geisinger, Mishra, Isom (CR17) 2010; 28 CR23 Zhu, Lee, Shim (CR6) 2011; 38 CR61 Vallbohmer, Holscher, Dietlein, Bollschweiler, Baldus, Monig (CR46) 2009; 250 Higuchi (10.1007/s11605-014-2488-2_bb0160) 2008; 136 Monjazeb (10.1007/s11605-014-2488-2_bb0090) 2010; 28 Siewert (10.1007/s11605-014-2488-2_bb0265) 2007; 246 Esteves (10.1007/s11605-014-2488-2_bb0065) 2006; 36 Wong (10.1007/s11605-014-2488-2_bb0075) 2008; 33 Wieder (10.1007/s11605-014-2488-2_bb0220) 2007; 34 Port (10.1007/s11605-014-2488-2_bb0095) 2007; 84 Lorenzen (10.1007/s11605-014-2488-2_bb0240) 2011; 13 Mamede (10.1007/s11605-014-2488-2_bb0085) 2007; 30 Swisher (10.1007/s11605-014-2488-2_bb0205) 2004; 78 Patnana (10.1007/s11605-014-2488-2_bb0260) 2010; 116 Makino (10.1007/s11605-014-2488-2_bb0200) 2010; 148 Smyth (10.1007/s11605-014-2488-2_bb0050) 2011; 17 Vallbohmer (10.1007/s11605-014-2488-2_bb0235) 2009; 250 Abdelsalam (10.1007/s11605-014-2488-2_bb0135) 2010; 3 10.1007/s11605-014-2488-2_bb0170 Weber (10.1007/s11605-014-2488-2_bb0210) 2001; 19 Swisher (10.1007/s11605-014-2488-2_bb0270) 2004; 101 Roedl (10.1007/s11605-014-2488-2_bb0105) 2008; 86 Lordick (10.1007/s11605-014-2488-2_bb0195) 2007; 8 Roedl (10.1007/s11605-014-2488-2_bb0100) 2009; 11 Higgins (10.1007/s11605-014-2488-2_bb0115) 2003; 327 Whiting (10.1007/s11605-014-2488-2_bb0275) 2013; 66 Kim (10.1007/s11605-014-2488-2_bb0190) 2007; 43 10.1007/s11605-014-2488-2_bb0120 10.1007/s11605-014-2488-2_bb0165 Ott (10.1007/s11605-014-2488-2_bb0255) 2006; 24 Lijmer (10.1007/s11605-014-2488-2_bb0295) 2002; 21 Vallbohmer (10.1007/s11605-014-2488-2_bb0030) 2010; 252 Suttie (10.1007/s11605-014-2488-2_bb0070) 2009; 35 Flamen (10.1007/s11605-014-2488-2_bb0155) 2002; 13 Makino (10.1007/s11605-014-2488-2_bb0245) 2008; 144 Chua (10.1007/s11605-014-2488-2_bb0055) 2011; 38 Juweid (10.1007/s11605-014-2488-2_bb0315) 2007; 25 Knottnerus (10.1007/s11605-014-2488-2_bb0300) 2002; 324 Kwee (10.1007/s11605-014-2488-2_bb0060) 2010; 254 Reid (10.1007/s11605-014-2488-2_bb0285) 1995; 274 Cuenca (10.1007/s11605-014-2488-2_bb0305) 2013; 40 Korst (10.1007/s11605-014-2488-2_bb0110) 2006; 82 10.1007/s11605-014-2488-2_bb0310 Zhu (10.1007/s11605-014-2488-2_bb0035) 2011; 38 Zum Buschenfelde (10.1007/s11605-014-2488-2_bb0230) 2011; 52 Downey (10.1007/s11605-014-2488-2_bb0145) 2003; 21 Luketich (10.1007/s11605-014-2488-2_bb0290) 1999; 68 Jemal (10.1007/s11605-014-2488-2_bb0010) 2011; 61 Riley (10.1007/s11605-014-2488-2_bb0130) 2007; 26 Juweid (10.1007/s11605-014-2488-2_bb0040) 2006; 354 Javeri (10.1007/s11605-014-2488-2_bb0175) 2009; 115 Whiting (10.1007/s11605-014-2488-2_bb0280) 2004; 140 10.1007/s11605-014-2488-2_bb0185 van Hagen (10.1007/s11605-014-2488-2_bb0020) 2012; 366 Gebski (10.1007/s11605-014-2488-2_bb0015) 2007; 8 Murthy (10.1007/s11605-014-2488-2_bb0250) 2010; 78 Duong (10.1007/s11605-014-2488-2_bb0150) 2006; 33 Malik (10.1007/s11605-014-2488-2_bb0080) 2010; 51 Riley (10.1007/s11605-014-2488-2_bb0125) 2007; 7 Yang (10.1007/s11605-014-2488-2_bb0225) 2011; 36 10.1007/s11605-014-2488-2_bb0180 Wieder (10.1007/s11605-014-2488-2_bb0215) 2004; 22 Wong (10.1007/s11605-014-2488-2_bb0045) 2012; 24 Brucher (10.1007/s11605-014-2488-2_bb0140) 2001; 233 Krause (10.1007/s11605-014-2488-2_bb0025) 2009; 50 |
References_xml | – volume: 140 start-page: 189 year: 2004 end-page: 202 ident: CR55 article-title: Sources of variation and bias in studies of diagnostic accuracy: a systematic review publication-title: Ann Intern Med doi: 10.7326/0003-4819-140-3-200402030-00010 contributor: fullname: Kleijnen – volume: 35 start-page: 1019 year: 2009 end-page: 1029 ident: CR13 article-title: Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2009.01.012 contributor: fullname: Park – volume: 25 start-page: 571 year: 2007 end-page: 578 ident: CR62 article-title: Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2305 contributor: fullname: Guermazi – volume: 50 start-page: 89S year: 2009 end-page: 96S ident: CR4 article-title: 18f-FDG PET and 18 F-FDG PET/CT for assessing response to therapy in esophageal cancer publication-title: J Nucl Med doi: 10.2967/jnumed.108.057232 contributor: fullname: Zum Buschenfelde – volume: 250 start-page: 888 year: 2009 end-page: 894 ident: CR46 article-title: [18 F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181bc9c0d contributor: fullname: Monig – volume: 66 start-page: 1093 year: 2013 end-page: 1104 ident: CR54 article-title: A systematic review classifies sources of bias and variation in diagnostic test accuracy studies publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.05.014 contributor: fullname: Group – volume: 33 start-page: 759 year: 2006 end-page: 769 ident: CR29 article-title: Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0028-8 contributor: fullname: Thomas – volume: 11 start-page: 54 year: 2009 end-page: 60 ident: CR19 article-title: Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus publication-title: Mol Imaging Biol doi: 10.1007/s11307-008-0169-9 contributor: fullname: Blake – ident: CR35 – ident: CR61 – volume: 26 start-page: 78 year: 2007 end-page: 97 ident: CR25 article-title: An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes publication-title: Stat Med doi: 10.1002/sim.2524 contributor: fullname: Thompson – volume: 28 start-page: 4714 year: 2010 end-page: 4721 ident: CR17 article-title: Outcomes of patients with esophageal cancer staged with [(1)F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? publication-title: J Clin Oncol doi: 10.1200/JCO.2010.30.7702 contributor: fullname: Isom – volume: 8 start-page: 797 year: 2007 end-page: 805 ident: CR38 article-title: Pet to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The Municon Phase II trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70244-9 contributor: fullname: Stein – volume: 43 start-page: 1385 year: 2007 end-page: 1391 ident: CR37 article-title: Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy publication-title: Eur J Cancer doi: 10.1016/j.ejca.2007.04.001 contributor: fullname: Park – volume: 24 start-page: 4692 year: 2006 end-page: 4698 ident: CR50 article-title: Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.7801 contributor: fullname: Herrmann – volume: 52 start-page: 1189 year: 2011 end-page: 1196 ident: CR45 article-title: 18f-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: The Municon II trial publication-title: J. Nucl. Med. doi: 10.2967/jnumed.110.085803 contributor: fullname: Becker – volume: 136 start-page: 205 year: 2008 end-page: 212 ident: CR31 article-title: Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma publication-title: J Thorac Cardiovasc Surg contributor: fullname: Tatsumi – volume: 148 start-page: 908 year: 2010 end-page: 918 ident: CR39 article-title: Utility of response evaluation to neo-adjuvant chemotherapy by 18 F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma publication-title: Surgery (USA) contributor: fullname: Nakajima – volume: 116 start-page: 4487 year: 2010 end-page: 4494 ident: CR51 article-title: Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography publication-title: Cancer doi: 10.1002/cncr.25431 contributor: fullname: Swisher – volume: 84 start-page: 393 year: 2007 end-page: 400 ident: CR18 article-title: Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2007.03.094 contributor: fullname: Christos – volume: 274 start-page: 645 year: 1995 end-page: 651 ident: CR56 article-title: Use of methodological standards in diagnostic test research. Getting better but still not good publication-title: JAMA doi: 10.1001/jama.1995.03530080061042 contributor: fullname: Feinstein – ident: CR32 – ident: CR36 – volume: 36 start-page: 860 year: 2011 end-page: 866 ident: CR44 article-title: Prediction of the outcome of definitive chemoradiation by decrease in F-18 FDG uptake in nonsurgical esophageal squamous cell cancer publication-title: Clin Nucl Med doi: 10.1097/RLU.0b013e318219b0c0 contributor: fullname: Kong – volume: 33 start-page: 183 year: 2008 end-page: 190 ident: CR14 article-title: Role of pet/pet ct in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: A literature review publication-title: Abdom Imaging doi: 10.1007/s00261-007-9241-1 contributor: fullname: Chambers – volume: 21 start-page: 428 year: 2003 end-page: 432 ident: CR28 article-title: Whole body 18fdg-pet and the response of esophageal cancer to induction therapy: results of a prospective trial publication-title: J Clin Oncol doi: 10.1200/JCO.2003.04.013 contributor: fullname: Gonen – volume: 51 start-page: 1863 year: 2010 end-page: 1869 ident: CR15 article-title: Early repeated 18 F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus publication-title: J Nucl Med doi: 10.2967/jnumed.110.079566 contributor: fullname: Keogan – volume: 86 start-page: 1131 year: 2008 end-page: 1138 ident: CR20 article-title: Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2008.05.019 contributor: fullname: Mathisen – volume: 21 start-page: 1525 year: 2002 end-page: 1537 ident: CR58 article-title: Exploring sources of heterogeneity in systematic reviews of diagnostic tests publication-title: Stat Med doi: 10.1002/sim.1185 contributor: fullname: Heisterkamp – volume: 246 start-page: 624 year: 2007 end-page: 628 ident: CR52 article-title: Induction chemotherapy in barrett cancer: influence on surgical risk and outcome publication-title: Ann Surg doi: 10.1097/SLA.0b013e318155a7d1 contributor: fullname: Becker – volume: 82 start-page: 480 year: 2006 end-page: 485 ident: CR21 article-title: Downstaging of t or n predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2006.03.072 contributor: fullname: Altorki – volume: 22 start-page: 900 year: 2004 end-page: 908 ident: CR42 article-title: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment publication-title: J Clin Oncol doi: 10.1200/JCO.2004.07.122 contributor: fullname: Beer – volume: 144 start-page: 793 year: 2008 end-page: 802 ident: CR48 article-title: Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma publication-title: Surgery doi: 10.1016/j.surg.2008.06.026 contributor: fullname: Fujiwara – volume: 17 start-page: 5059 year: 2011 end-page: 5074 ident: CR9 article-title: Role of (1)F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies publication-title: World J Gastroenterol doi: 10.3748/wjg.v17.i46.5059 contributor: fullname: Shah – ident: CR33 – volume: 13 start-page: 361 year: 2002 end-page: 368 ident: CR30 article-title: Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdf081 contributor: fullname: Bormans – volume: 324 start-page: 477 year: 2002 end-page: 480 ident: CR59 article-title: Evaluation of diagnostic procedures publication-title: BMJ doi: 10.1136/bmj.324.7335.477 contributor: fullname: Muris – volume: 19 start-page: 3058 year: 2001 end-page: 3065 ident: CR41 article-title: Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging publication-title: J Clin Oncol contributor: fullname: Avril – volume: 8 start-page: 226 year: 2007 end-page: 234 ident: CR2 article-title: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70039-6 contributor: fullname: Simes – volume: 30 start-page: 377 year: 2007 end-page: 388 ident: CR16 article-title: FDG-pet/ct tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: Correlation with histopathology results publication-title: Am J Clin Oncol doi: 10.1097/COC.0b013e31803993f8 contributor: fullname: Gerbaudo – volume: 254 start-page: 707 year: 2010 end-page: 717 ident: CR11 article-title: Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18 F FDG PET: a systematic review publication-title: Radiology doi: 10.1148/radiol.09091324 contributor: fullname: Kwee – ident: CR23 – volume: 327 start-page: 557 year: 2003 end-page: 560 ident: CR22 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 contributor: fullname: Altman – volume: 7 start-page: 3 year: 2007 ident: CR24 article-title: Bivariate random-effects meta-analysis and the estimation of between-study correlation publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-7-3 contributor: fullname: Thompson – volume: 252 start-page: 744 year: 2010 end-page: 749 ident: CR5 article-title: A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181fb8dde contributor: fullname: Peters – volume: 78 start-page: 1152 year: 2004 end-page: 1160 ident: CR40 article-title: Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2004.04.046 contributor: fullname: Bresalier – volume: 366 start-page: 2074 year: 2012 end-page: 2084 ident: CR3 article-title: Preoperative chemoradiotherapy for esophageal or junctional cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1112088 contributor: fullname: Wijnhoven – volume: 68 start-page: 1133 year: 1999 end-page: 1136 ident: CR57 article-title: Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(99)00974-1 contributor: fullname: Townsend – volume: 61 start-page: 69 year: 2011 end-page: 90 ident: CR1 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 contributor: fullname: Forman – volume: 78 start-page: 316 year: 2010 end-page: 322 ident: CR49 article-title: The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma publication-title: Oncology (Switzerland) contributor: fullname: Swisher – volume: 40 start-page: 477 year: 2013 end-page: 485 ident: CR60 article-title: Evaluation of early response to concomitant chemoradiotherapy by interim (18)F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2325-3 contributor: fullname: Baruch-Hennequin – volume: 36 start-page: 169 year: 2006 end-page: 181 ident: CR12 article-title: Gastrointestinal tract malignancies and positron emission tomography: an overview publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2005.12.002 contributor: fullname: Halkar – volume: 38 start-page: 55 year: 2011 end-page: 69 ident: CR6 article-title: Metabolic positron emission tomography imaging in cancer detection and therapy response publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2010.11.012 contributor: fullname: Shim – volume: 354 start-page: 496 year: 2006 end-page: 507 ident: CR7 article-title: Positron-emission tomography and assessment of cancer therapy publication-title: N Engl J Med doi: 10.1056/NEJMra050276 contributor: fullname: Cheson – volume: 24 start-page: 86 year: 2012 end-page: 104 ident: CR8 article-title: Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer publication-title: Clin. Oncol. doi: 10.1016/j.clon.2011.09.006 contributor: fullname: Raifu – volume: 115 start-page: 5184 year: 2009 end-page: 5192 ident: CR34 article-title: The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma publication-title: Cancer doi: 10.1002/cncr.24604 contributor: fullname: Hofstetter – volume: 3 start-page: 179 year: 2010 end-page: 184 ident: CR26 article-title: Whole body 18 F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial publication-title: Hematol. Oncolog. Stem Cell Ther. contributor: fullname: Rahal – volume: 233 start-page: 300 year: 2001 end-page: 309 ident: CR27 article-title: Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography publication-title: Ann Surg doi: 10.1097/00000658-200103000-00002 contributor: fullname: Stein – volume: 13 start-page: 178 year: 2011 end-page: 186 ident: CR47 article-title: Association of the VEGF 936C > T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction publication-title: Mol Imaging Biol doi: 10.1007/s11307-010-0330-0 contributor: fullname: Becker – volume: 101 start-page: 1776 year: 2004 end-page: 1785 ident: CR53 article-title: 2-Fluoro-2-deoxy- -glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma publication-title: Cancer doi: 10.1002/cncr.20585 contributor: fullname: Ajani – volume: 38 start-page: 1591 year: 2011 end-page: 1594 ident: CR10 article-title: PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-011-1858-1 contributor: fullname: Groves – volume: 34 start-page: 1925 year: 2007 end-page: 1932 ident: CR43 article-title: Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-007-0521-3 contributor: fullname: Herrmann – volume: 115 start-page: 5184 year: 2009 ident: 10.1007/s11605-014-2488-2_bb0175 article-title: The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma publication-title: Cancer doi: 10.1002/cncr.24604 contributor: fullname: Javeri – volume: 33 start-page: 183 year: 2008 ident: 10.1007/s11605-014-2488-2_bb0075 article-title: Role of pet/pet ct in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: A literature review publication-title: Abdom Imaging doi: 10.1007/s00261-007-9241-1 contributor: fullname: Wong – ident: 10.1007/s11605-014-2488-2_bb0185 doi: 10.3109/0284186X.2011.643822 – volume: 43 start-page: 1385 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0190 article-title: Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy publication-title: Eur J Cancer doi: 10.1016/j.ejca.2007.04.001 contributor: fullname: Kim – volume: 61 start-page: 69 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0010 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 contributor: fullname: Jemal – volume: 26 start-page: 78 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0130 article-title: An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes publication-title: Stat Med doi: 10.1002/sim.2524 contributor: fullname: Riley – volume: 68 start-page: 1133 year: 1999 ident: 10.1007/s11605-014-2488-2_bb0290 article-title: Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans publication-title: Ann Thorac Surg contributor: fullname: Luketich – volume: 8 start-page: 797 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0195 article-title: Pet to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The Municon Phase II trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70244-9 contributor: fullname: Lordick – volume: 148 start-page: 908 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0200 article-title: Utility of response evaluation to neo-adjuvant chemotherapy by 18 F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma publication-title: Surgery (USA) contributor: fullname: Makino – volume: 116 start-page: 4487 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0260 article-title: Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography publication-title: Cancer doi: 10.1002/cncr.25431 contributor: fullname: Patnana – volume: 254 start-page: 707 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0060 article-title: Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18 F FDG PET: a systematic review publication-title: Radiology doi: 10.1148/radiol.09091324 contributor: fullname: Kwee – volume: 101 start-page: 1776 year: 2004 ident: 10.1007/s11605-014-2488-2_bb0270 article-title: 2-Fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma publication-title: Cancer doi: 10.1002/cncr.20585 contributor: fullname: Swisher – volume: 252 start-page: 744 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0030 article-title: A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181fb8dde contributor: fullname: Vallbohmer – volume: 38 start-page: 1591 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0055 article-title: PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-011-1858-1 contributor: fullname: Chua – volume: 33 start-page: 759 year: 2006 ident: 10.1007/s11605-014-2488-2_bb0150 article-title: Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0028-8 contributor: fullname: Duong – volume: 82 start-page: 480 year: 2006 ident: 10.1007/s11605-014-2488-2_bb0110 article-title: Downstaging of t or n predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2006.03.072 contributor: fullname: Korst – volume: 21 start-page: 1525 year: 2002 ident: 10.1007/s11605-014-2488-2_bb0295 article-title: Exploring sources of heterogeneity in systematic reviews of diagnostic tests publication-title: Stat Med doi: 10.1002/sim.1185 contributor: fullname: Lijmer – volume: 19 start-page: 3058 year: 2001 ident: 10.1007/s11605-014-2488-2_bb0210 article-title: Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging publication-title: J Clin Oncol doi: 10.1200/JCO.2001.19.12.3058 contributor: fullname: Weber – volume: 327 start-page: 557 year: 2003 ident: 10.1007/s11605-014-2488-2_bb0115 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 contributor: fullname: Higgins – volume: 233 start-page: 300 year: 2001 ident: 10.1007/s11605-014-2488-2_bb0140 article-title: Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography publication-title: Ann Surg doi: 10.1097/00000658-200103000-00002 contributor: fullname: Brucher – volume: 66 start-page: 1093 year: 2013 ident: 10.1007/s11605-014-2488-2_bb0275 article-title: A systematic review classifies sources of bias and variation in diagnostic test accuracy studies publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.05.014 contributor: fullname: Whiting – ident: 10.1007/s11605-014-2488-2_bb0170 doi: 10.1007/s10147-011-0278-3 – volume: 11 start-page: 54 year: 2009 ident: 10.1007/s11605-014-2488-2_bb0100 article-title: Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus publication-title: Mol Imaging Biol doi: 10.1007/s11307-008-0169-9 contributor: fullname: Roedl – volume: 36 start-page: 860 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0225 article-title: Prediction of the outcome of definitive chemoradiation by decrease in F-18 FDG uptake in nonsurgical esophageal squamous cell cancer publication-title: Clin Nucl Med doi: 10.1097/RLU.0b013e318219b0c0 contributor: fullname: Yang – volume: 354 start-page: 496 year: 2006 ident: 10.1007/s11605-014-2488-2_bb0040 article-title: Positron-emission tomography and assessment of cancer therapy publication-title: N Engl J Med doi: 10.1056/NEJMra050276 contributor: fullname: Juweid – volume: 78 start-page: 316 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0250 article-title: The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma publication-title: Oncology (Switzerland) contributor: fullname: Murthy – ident: 10.1007/s11605-014-2488-2_bb0120 doi: 10.1007/s11121-013-0377-7 – volume: 324 start-page: 477 year: 2002 ident: 10.1007/s11605-014-2488-2_bb0300 article-title: Evaluation of diagnostic procedures publication-title: BMJ doi: 10.1136/bmj.324.7335.477 contributor: fullname: Knottnerus – volume: 38 start-page: 55 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0035 article-title: Metabolic positron emission tomography imaging in cancer detection and therapy response publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2010.11.012 contributor: fullname: Zhu – volume: 17 start-page: 5059 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0050 article-title: Role of (1)F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies publication-title: World J Gastroenterol doi: 10.3748/wjg.v17.i46.5059 contributor: fullname: Smyth – volume: 13 start-page: 178 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0240 article-title: Association of the VEGF 936C > T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction publication-title: Mol Imaging Biol doi: 10.1007/s11307-010-0330-0 contributor: fullname: Lorenzen – volume: 50 start-page: 89S year: 2009 ident: 10.1007/s11605-014-2488-2_bb0025 article-title: 18f-FDG PET and 18 F-FDG PET/CT for assessing response to therapy in esophageal cancer publication-title: J Nucl Med doi: 10.2967/jnumed.108.057232 contributor: fullname: Krause – volume: 22 start-page: 900 year: 2004 ident: 10.1007/s11605-014-2488-2_bb0215 article-title: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment publication-title: J Clin Oncol doi: 10.1200/JCO.2004.07.122 contributor: fullname: Wieder – volume: 78 start-page: 1152 year: 2004 ident: 10.1007/s11605-014-2488-2_bb0205 article-title: Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2004.04.046 contributor: fullname: Swisher – volume: 13 start-page: 361 year: 2002 ident: 10.1007/s11605-014-2488-2_bb0155 article-title: Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdf081 contributor: fullname: Flamen – volume: 35 start-page: 1019 year: 2009 ident: 10.1007/s11605-014-2488-2_bb0070 article-title: Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2009.01.012 contributor: fullname: Suttie – volume: 51 start-page: 1863 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0080 article-title: Early repeated 18 F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus publication-title: J Nucl Med doi: 10.2967/jnumed.110.079566 contributor: fullname: Malik – volume: 21 start-page: 428 year: 2003 ident: 10.1007/s11605-014-2488-2_bb0145 article-title: Whole body 18fdg-pet and the response of esophageal cancer to induction therapy: results of a prospective trial publication-title: J Clin Oncol doi: 10.1200/JCO.2003.04.013 contributor: fullname: Downey – volume: 3 start-page: 179 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0135 article-title: Whole body 18 F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial publication-title: Hematol. Oncolog. Stem Cell Ther. doi: 10.5144/1658-3876.2010.179 contributor: fullname: Abdelsalam – volume: 250 start-page: 888 year: 2009 ident: 10.1007/s11605-014-2488-2_bb0235 article-title: [18 F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181bc9c0d contributor: fullname: Vallbohmer – volume: 140 start-page: 189 year: 2004 ident: 10.1007/s11605-014-2488-2_bb0280 article-title: Sources of variation and bias in studies of diagnostic accuracy: a systematic review publication-title: Ann Intern Med doi: 10.7326/0003-4819-140-3-200402030-00010 contributor: fullname: Whiting – volume: 7 start-page: 3 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0125 article-title: Bivariate random-effects meta-analysis and the estimation of between-study correlation publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-7-3 contributor: fullname: Riley – volume: 8 start-page: 226 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0015 article-title: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70039-6 contributor: fullname: Gebski – volume: 86 start-page: 1131 year: 2008 ident: 10.1007/s11605-014-2488-2_bb0105 article-title: Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2008.05.019 contributor: fullname: Roedl – volume: 136 start-page: 205 year: 2008 ident: 10.1007/s11605-014-2488-2_bb0160 article-title: Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2008.02.016 contributor: fullname: Higuchi – volume: 52 start-page: 1189 year: 2011 ident: 10.1007/s11605-014-2488-2_bb0230 article-title: 18f-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: The Municon II trial publication-title: J. Nucl. Med. doi: 10.2967/jnumed.110.085803 contributor: fullname: Zum Buschenfelde – volume: 84 start-page: 393 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0095 article-title: Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2007.03.094 contributor: fullname: Port – volume: 25 start-page: 571 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0315 article-title: Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2305 contributor: fullname: Juweid – volume: 24 start-page: 4692 year: 2006 ident: 10.1007/s11605-014-2488-2_bb0255 article-title: Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.7801 contributor: fullname: Ott – volume: 274 start-page: 645 year: 1995 ident: 10.1007/s11605-014-2488-2_bb0285 article-title: Use of methodological standards in diagnostic test research. Getting better but still not good publication-title: JAMA doi: 10.1001/jama.1995.03530080061042 contributor: fullname: Reid – volume: 366 start-page: 2074 year: 2012 ident: 10.1007/s11605-014-2488-2_bb0020 article-title: Preoperative chemoradiotherapy for esophageal or junctional cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1112088 contributor: fullname: van Hagen – ident: 10.1007/s11605-014-2488-2_bb0310 doi: 10.1259/bjr/29946900 – volume: 24 start-page: 86 year: 2012 ident: 10.1007/s11605-014-2488-2_bb0045 article-title: Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer publication-title: Clin. Oncol. doi: 10.1016/j.clon.2011.09.006 contributor: fullname: Wong – volume: 30 start-page: 377 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0085 article-title: FDG-pet/ct tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: Correlation with histopathology results publication-title: Am J Clin Oncol doi: 10.1097/COC.0b013e31803993f8 contributor: fullname: Mamede – volume: 40 start-page: 477 year: 2013 ident: 10.1007/s11605-014-2488-2_bb0305 article-title: Evaluation of early response to concomitant chemoradiotherapy by interim (18)F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2325-3 contributor: fullname: Cuenca – volume: 28 start-page: 4714 year: 2010 ident: 10.1007/s11605-014-2488-2_bb0090 article-title: Outcomes of patients with esophageal cancer staged with [(1)F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? publication-title: J Clin Oncol doi: 10.1200/JCO.2010.30.7702 contributor: fullname: Monjazeb – volume: 36 start-page: 169 year: 2006 ident: 10.1007/s11605-014-2488-2_bb0065 article-title: Gastrointestinal tract malignancies and positron emission tomography: an overview publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2005.12.002 contributor: fullname: Esteves – volume: 246 start-page: 624 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0265 article-title: Induction chemotherapy in barrett cancer: influence on surgical risk and outcome publication-title: Ann Surg doi: 10.1097/SLA.0b013e318155a7d1 contributor: fullname: Siewert – ident: 10.1007/s11605-014-2488-2_bb0180 doi: 10.1016/j.ijrobp.2011.12.029 – ident: 10.1007/s11605-014-2488-2_bb0165 doi: 10.1002/cncr.26591 – volume: 34 start-page: 1925 year: 2007 ident: 10.1007/s11605-014-2488-2_bb0220 article-title: Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-007-0521-3 contributor: fullname: Wieder – volume: 144 start-page: 793 year: 2008 ident: 10.1007/s11605-014-2488-2_bb0245 article-title: Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma publication-title: Surgery doi: 10.1016/j.surg.2008.06.026 contributor: fullname: Makino |
SSID | ssj0017018 |
Score | 2.3079545 |
Snippet | Purpose
We studied the predictive value of [
18
F]fluorodeoxyglucose-positron emission tomography (
18
FDG-PET) for assessing disease-free (DFS) and overall... |
SourceID | crossref springer |
SourceType | Aggregation Database Publisher |
StartPage | 894 |
SubjectTerms | Gastroenterology Medicine Medicine & Public Health Original Article Surgery |
Title | A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification |
URI | https://link.springer.com/article/10.1007/s11605-014-2488-2 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA4-QLz4Fp_LHDwpWbZt-joW3XVRfMDuynoqaZOID7qythd_lr_QmT5WRD0I7aEhNC3fZGYyk3zD2JG0NPFG2VxJZbjwXMWlEorbJvRcU3opFO-4uvb6I3ExdsdzzJ6FLrLndpORLBX111k3yyv3mQluC0J3ni2i6aHJuBid3192Z7kDv2NVB-BCi6PDPG5ymb-95Ls1-p4KLS1Mb7U69fdWEhPSxpLndpEn7fT9J23jPz5-ja3UDidElYSsszmdbbClqzqlvsk-IhjM2JyhShXAxAA6hnA7pW6kEOFOvhSa2q2gd3bOb7tDeMygS0UQUCPhADJTzePkQVI1kBQu0GgS8HBKsjWFiAqSw7WeSPVUoAufA_EVoBCqSkAALxp3UKACwykAN0WOP4gNJbmvqeOLW2zU6w5P-7wu5MBTtH45R9Dd1PdxNSwsqUOVOB28g0RLpxNKoxw7UFp60rUcGYaJn-jA08pNXMpTCvSZttlCNsn0DgPH-Fo5ItWoagQup2SoTdAJjEmJiM2Ru-y4ATR-rfg64i9mZkIhRhRiQiG2d9lJA1dcT923v3vv_av3Plu2Ce8S9gO2kE8LfYj-S560aoFtsfmRHX0CctPpVw |
link.rule.ids | 314,780,784,27924,27925,41081,41523,42150,42592,52111,52234 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF58gHoRn1ifc_CkLDTJ5nUs2lprWwttpbewye6KIqm0yR_zFzqThyLoQUgOWZYE9pvMfLuz-w1jl9LSpBtlcyWV4cJzFZdKKG6b0HNNwVJovWMw9LpT0Zu5s-oc97Le7V6nJAtP_X3YzfKKjWaC24LgXWXraHAhlS2Y2q2v1IHftMrzb6HFkS_P6lTmb6_4GYx-ZkKLANPZYdsVM4RWCeUuW9HpHtsYVLnvffbRgvGX7DKUa_owN4AMDkYL6kaeC57kW66p3Qo6t3d81J7ASwptqlaArgM_IFNVP86fJZXtSKCH0Y0QghsyggW0qHI4DPVcqtccuXYGJCyA1qJKJAEv-u44R0-DtgqPeYajiA2FCq-pFgIP2LTTntx0eVVxgScYpjKO6LiJ7-O0VVhShyp2mngHsZZOM5RGOXagtPSkazkyDGM_1oGnlRu7lFAUSG4O2Vo6T_URA8f4Wjki0egTBM57ZKhN0AyMSUgxzZENdlUPffReCmtE3xLKhFOEOEWEU2Q32HUNTlT9Y8u_ex__q_cF2-xOBv2ofz98OGFbNllHYSSnbC1b5PoMSUcWnxdG9gl1Rs-K |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF60gngRn_h2Dp6UxSbZvI6lD7VqLWilt7DJ7ooiqbTJH_MXOpNHS0EPQnLIsiSw35eZ2Z3dbxi7kJYm3SibK6kMF56ruFRCcduEnmuKKIXWOx4H3u1I9MfuuKpzOqt3u9cpyfJMA6k0pdn1lzLXi4NvlldsOhPcFgT1KlsjT0REH9mteRrBb1rlWbjQ4hg7j-u05m-vWHZMy1nRwtn0tthmFSVCq4R1m63odIetP1Z58F323YLnuQQzlOv7MDGA0RwMp9SNrBi8ys9cU7sV9Do3fNh9gfcUulS5AM0IfkCmqn6cvEkq4ZFAHz0doQVtIsQUWlRFHAZ6ItVHjnF3BiQygMxRJaqAF333OUerg7yFpzzDEcWGQpHXVIuCe2zU6760b3lVfYEn6LIyjki5ie_jFFZYUocqdpp4B7GWTjOURjl2oLT0pGs5MgxjP9aBp5Ubu5RcFBjo7LNGOkn1AQPH-Fo5ItFoHwTOgWSoTdAMjElIPc2Rh-yyHvroqxTZiBZyyoRThDhFhFNkH7KrGpyo-t9mf_c--lfvc7Y-7PSih7vB_THbsIkcBUdOWCOb5voU448sPis49gN9HdPG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Systematic+Review+of+the+Predictive+Value+of+18FDG-PET+in+Esophageal+and+Esophagogastric+Junction+Cancer+After+Neoadjuvant+Chemoradiation+on+the+Survival+Outcome+Stratification&rft.jtitle=Journal+of+gastrointestinal+surgery&rft.au=Schollaert%2C+Pascaline&rft.au=Crott%2C+Ralph&rft.au=Bertrand%2C+Claude&rft.au=D%E2%80%99Hondt%2C+Lionel&rft.date=2014-05-01&rft.issn=1091-255X&rft.volume=18&rft.issue=5&rft.spage=894&rft.epage=905&rft_id=info:doi/10.1007%2Fs11605-014-2488-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11605_014_2488_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-255X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-255X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-255X&client=summon |